期刊
EUROPEAN JOURNAL OF NEUROLOGY
卷 23, 期 12, 页码 1705-1712出版社
WILEY-BLACKWELL
DOI: 10.1111/ene.13071
关键词
body mass index; intravenous thrombolysis; outcome; stroke; symptomatic intracranial haemorrhage
资金
- Boehringer-Ingelheim
- Nestec
- Swiss Heart Foundation
- Swiss National Science Foundation
- University of Basel
- Bayer
- Covidien
- Stryker
- Pierre-Fabre
- AstraZeneca
- CHUV
- Bayer Schering Pharma
- Boehringer Ingelheim
- Shire plc
- Sanofi-aventis
- PhotoThera
- Pfizer
- Science Funds (Wissenschaftsfonds) of the University Hospital Basel
- University Basel
Background and purposeThe impact of body mass index (BMI) on outcome in stroke patients treated with intravenous thrombolysis (IVT) was investigated. MethodsIn a multicentre IVT-register-based observational study, BMI with (i) poor 3-month outcome (i.e. modified Rankin Scale scores 3-6), (ii) death and (iii) symptomatic intracranial haemorrhage (sICH) based on criteria of the ECASS II trial was compared. BMI was used as a continuous and categorical variable distinguishing normal weight (reference group 18.5-24.9 kg/m(2)) from underweight (<18.5 kg/m(2)), overweight (25-29.9 kg/m(2)) and obese (30 kg/m(2)) patients. Univariable and multivariable regression analyses with adjustments for age and stroke severity were done and odds ratios with 95% confidence intervals [OR (95% CI)] were calculated. ResultsOf 1798 patients, 730 (40.6%) were normal weight, 55 (3.1%) were underweight, 717 (39.9%) overweight and 295 (16.4%) obese. Poor outcome occurred in 38.1% of normal weight patients and did not differ significantly from underweight (45.5%), overweight (36.1%) and obese (32.5%) patients. The same was true for death (9.5% vs. 14.5%, 9.6% and 7.5%) and sICH (3.9% vs. 5.5%, 4.3%, 2.7%). Neither in univariable nor in multivariable analyses did the risks of poor outcome, death or sICH differ significantly between BMI groups. BMI as a continuous variable was not associated with poor outcome, death or sICH in unadjusted [OR (95% CI) 0.99 (0.97-1.01), 0.98 (0.95-1.02), 0.98 (0.94-1.04)] or adjusted analyses [OR (95% CI) 1.01 (0.98-1.03), 0.99 (0.95-1.05), 1.01 (0.97-1.05)], respectively. ConclusionIn this largest study to date, investigating the impact of BMI in IVT-treated stroke patients, BMI had no prognostic meaning with regard to 3-month functional outcome, death or occurrence of sICH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据